Knowing risk is the best way to mange it. Read on to find the different type of risk involved while investing in mutual fund. 

Tata Steel's subsidiary, TSGH has agreed to divest its equity stakes held in China-based NatSteel Holdings and Tata Steel Thailand to a new entity which will be controlled by HBIS Group. This strategic partnership will help Tata Steel expand its south-east Asia business.

Reacting to the pledge invocation, the company’s management clarified that it was in talks with its lenders who have agreed not to invoke the pledge on promoters shares. The company’s promoters have given assurance that they can carry out the strategic stake sale in a time-bound manner.

Hyderabad-based Natco Pharma has launched Valsartan-Sacubitril tablet under its brand VALSAC, the company informed the bourses. This tablet is used for certain types of heart failure and keeps blood vessels from narrowing.

Banks pull down markets massively. Nifty Bank was down 478.45 points or 1.76 per cent. Pharma stocks also experienced selling pressure. Other than IT and media all sectorial indices were trading in red.

When it comes to debt funds, people usually compare it with equity funds in terms of returns and refrain from investing in them. So is dynamic bond funds worth investing in? Let’s find out.

Following stocks are close to their 52-week low as at 12.50 p.m. on January 28, 2019.

The markets on January 28, 2019 opened gap down. BSE Sensex is trading at 35,690.77, down by 334.77 points and the Nifty is trading at 10,680.70, down by 99.85 points. 

V2 Retail Limited reported its results for the quarter ended December 30, 2018 on Friday. The company registered a 58.2 per cent YoY increase in its standalone revenue for the quarter.

The pharma major Cipla was experiencing selling pressure on Monday. The company informed the bourses that it has received final USFDA approval for medroxyprogesterone injectable.